These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 8803882)

  • 1. A study of the effect of a platelet activating factor (PAF) receptor antagonist on antigen challenge of horses with chronic obstructive pulmonary disease.
    Marr KA; Fairbairn SM; Page CP; Lees P; Cunningham FM
    J Vet Pharmacol Ther; 1996 Jun; 19(3):233-7. PubMed ID: 8803882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of platelet activating factor on the distribution of radiolabelled leucocytes and platelets in normal horses and asymptomatic horses with chronic obstructive pulmonary disease.
    Fairbairn SM; Marr KA; Lees P; Cunningham FM; Page CP
    Res Vet Sci; 1996 Sep; 61(2):107-13. PubMed ID: 8880978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Actions of PAF receptor antagonists in horses with the allergic skin disease sweet itch.
    Foster AP; Lees P; Cunningham FM
    Inflamm Res; 1995 Oct; 44(10):412-7. PubMed ID: 8564516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of WEB 2086, an antagonist to the receptor for platelet-activating factor (PAF), on PAF-induced responses in the horse.
    Foster AP; Lees P; Andrews MJ; Cunningham FM
    Equine Vet J; 1992 May; 24(3):203-7. PubMed ID: 1318830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of the 5-lipoxygenase inhibitor, fenleuton, on antigen-induced neutrophil accumulation and lung function changes in horses with chronic obstructive pulmonary disease.
    Marr KA; Lees P; Page CP; Cunningham FM
    J Vet Pharmacol Ther; 1998 Jun; 21(3):241-6. PubMed ID: 9673966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of platelet activating factor receptor antagonists on intracellular platelet activating factor function in neutrophils.
    Koike H; Imanishi N; Natsume Y; Morooka S
    Eur J Pharmacol; 1994 Nov; 269(3):299-309. PubMed ID: 7895770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of the actions of platelet activating factor (PAF) antagonists WEB 2170 and WEB 2086 in the horse.
    Foster AP; Cunningham FM; Andrews MJ; Lees P
    J Vet Pharmacol Ther; 1993 Dec; 16(4):477-87. PubMed ID: 8126765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Scorpion venom-induced neutrophilia is inhibited by a PAF receptor antagonist in the rat.
    Borges CM; Silveira MR; Aparecida M; Beker CL; Freire-Maia L; Teixeira MM
    J Leukoc Biol; 2000 Apr; 67(4):515-9. PubMed ID: 10770284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased neutrophil-endothelial adhesion induced by placental factors is mediated by platelet-activating factor in preeclampsia.
    Wang Y; Adair CD; Weeks JW; Lewis DF; Alexander JS
    J Soc Gynecol Investig; 1999; 6(3):136-41. PubMed ID: 10376269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of WEB 2086-BS, an antagonist of platelet-activating factor receptors, on retinal vascularity in diabetic rats.
    de la Cruz JP; Moreno A; Ruiz-Ruiz MI; García-Campos J; Sánchez de la Cuesta F
    Eur J Pharmacol; 1998 Oct; 360(1):37-42. PubMed ID: 9845270
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early neutrophil but not eosinophil or platelet recruitment to the lungs of allergic horses following antigen exposure.
    Fairbairn SM; Page CP; Lees P; Cunningham FM
    Clin Exp Allergy; 1993 Oct; 23(10):821-8. PubMed ID: 10780888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Administration of a receptor antagonist for platelet-activating factor during equine endotoxaemia.
    Carrick JB; Morris DD; Moore JN
    Equine Vet J; 1993 Mar; 25(2):152-7. PubMed ID: 8385601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet-activating factor contributes to acute lung leak in rats given interleukin-1 intratracheally.
    Lee YM; Hybertson BM; Cho HG; Terada LS; Cho O; Repine AJ; Repine JE
    Am J Physiol Lung Cell Mol Physiol; 2000 Jul; 279(1):L75-80. PubMed ID: 10893205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipopolysaccharide-induced pleural neutrophil accumulation depends on marrow neutrophils and platelet-activating factor.
    Bozza PT; Castro-Faria-Neto HC; Silva AR; Larangeira AP; Silva PM; Martins MA; Cordeiro RS
    Eur J Pharmacol; 1994 Apr; 270(2-3):143-9. PubMed ID: 8039544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential inhibition of equine neutrophil function by phosphodiesterase inhibitors.
    Rickards KJ; Page CP; Lees P; Cunningham FM
    J Vet Pharmacol Ther; 2001 Aug; 24(4):275-81. PubMed ID: 11555183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of PAF-induced platelet aggregation by WEB 2086 'in-vitro', an antagonist to the receptor for platelet-activating factor, in bovine.
    da Silva MB; Herion F; Raskinet R; David JL; Gustin P; Dessy C; Lekeux P
    Zentralbl Veterinarmed A; 1996 Sep; 43(7):399-413. PubMed ID: 8921726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppressive effects of Y-24180, a receptor antagonist to platelet activating factor (PAF), on antigen-induced asthmatic responses in guinea pigs.
    Kagoshima M; Tomomatsu N; Iwahisa Y; Yamaguchi S; Matsuura M; Kawakami Y; Terasawa M
    Inflamm Res; 1997 Apr; 46(4):147-53. PubMed ID: 9137994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet-activating factor (PAF) receptor antagonism by WEB 2170 improves the survival of ischaemic skeletal muscle.
    Lepore DA; Knight KR; Stewart AG; Riccio M; Morrison WA
    Ann Acad Med Singap; 1995 Jul; 24(4 Suppl):63-7. PubMed ID: 8572529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Y-24180, a long-acting antagonist to platelet-activating factor (PAF), on PAF-induced reactions: a relationship between the partial structure of the compound and its duration of the action.
    Kagoshima M; Tomomatsu N; Iwahisa Y; Yamaguchi S; Kawakami Y; Terasawa M
    Pharmacology; 1997 May; 54(5):261-70. PubMed ID: 9380772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sensitization of human neutrophil defense activities through activation of platelet-activating factor receptors by ginkgolide B, a bioactive component of the Ginkgo biloba extract EGB 761.
    Lenoir M; Pedruzzi E; Rais S; Drieu K; Perianin A
    Biochem Pharmacol; 2002 Apr; 63(7):1241-9. PubMed ID: 11960600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.